One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) - Global Forecast to 2027


Product Code : MNMHC00109662
Survey : MarketsandMarkets
Publish On : 20, June, 2022
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global infectious disease diagnostics market is projected to grow at a CAGR of 5.6%.”
The global infectious disease diagnostics market is expected to reach USD 19.35 billion by 2022 from USD 14.73 billion in 2017, at a CAGR of 5.6%. Growth in this market can primarily be attributed to factors such as increasing global prevalence of infectious diseases, shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on infectious disease diagnostics. However, inadequate reimbursement and rising healthcare cost limiting usage of novel diagnostic technologies are expected to restrain the growth of this market during the forecast period.
“The assays, kits, & reagents segment accounted for the largest share in 2017.”
Based on product & service, the infectious disease diagnostics market is segmented into assays, kits, & reagents; instruments; and services & software. The assays, kits, and reagents segment accounted for the largest share of the global infectious disease diagnostics market in 2017. The large share of this segment can be attributed to the increasing number of infectious disease diagnostic tests carried out; easy accessibility to a wide range of reagents; and the growing need for reliable, specific, and faster detection of infectious diseases in the early stages.
“Asia Pacific is projected to grow at the highest CAGR during the forecast period.”
Geographically, Asia Pacific is expected to register the highest CAGR during the forecast period. The growth of this regional segment can be attributed to the growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
Break-up profile of primaries:
• By Company Type- Tier 40%, Tier 30%, and Tier 30%
• By Designation-C-level-27%, D-level-18%, and Others-55%
• By Region-North America-50%, Europe-20%, Asia Pacific-20%, and RoW-10%
The key players in the global infectious disease diagnostics market are Abbott (US), Becton, Dickinson and Company (BD) (US), bioMerieux (France), Bio-Rad (US), and Roche (Switzerland).
Research Coverage:
The infectious disease diagnostics market in this report is segmented by product & service, disease type, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches & approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and profiles key players and core competencies in the infectious disease diagnostics market.
Reasons to buy this report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on portfolios offered by the top players in the global infectious disease diagnostics market. The report analyzes the market by product & service, disease type, technology, end user, and region
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global infectious disease diagnostics market
Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for infectious disease diagnostic products across regions
Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global infectious disease diagnostics market
Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global infectious disease diagnostics market

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 16
1.2.1 MARKETS COVERED 16
1.2.2 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
1.4 LIMITATIONS 17
1.5 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 PRIMARY DATA 19
2.1.1 KEY DATA FROM PRIMARY SOURCES 19
2.1.2 KEY INDUSTRY INSIGHTS 20
2.2 SECONDARY DATA 21
2.2.1 KEY DATA FROM SECONDARY SOURCES 21
2.3 MARKET SIZE ESTIMATION 22
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 24
2.4.1 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
4 PREMIUM INSIGHTS 30
4.1 INFECTIOUS DISEASE DIAGNOSTICS: MARKET OVERVIEW 30
4.2 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY AND REGION (2017) 31
4.3 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2017 VS. 2022 (USD BILLION) 32
4.4 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER 32
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Increasing global prevalence of infectious diseases 34
5.2.1.2 Shift in focus from centralized laboratories to decentralized point-of-care testing 34
5.2.1.3 Growth in funding for research on infectious disease diagnostics 35
5.2.2 RESTRAINTS 35
5.2.2.1 Inadequate reimbursements 35
5.2.2.2 Rising healthcare costs limiting the use of novel diagnostic techniques 36
5.2.3 OPPORTUNITIES 36
5.2.3.1 Advances in genomics and proteomics 36
5.2.3.2 Growing awareness about personalized medicine 37
5.2.3.3 Growth opportunities in emerging markets 37
6 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 38
6.1 INTRODUCTION 39
6.2 ASSAYS, KITS, & REAGENTS 40
6.3 INSTRUMENTS 41
6.4 SERVICES & SOFTWARE 42
7 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY 44
7.1 INTRODUCTION 45
7.1.1 IMMUNODIAGNOSTICS 46
7.1.2 CLINICAL MICROBIOLOGY 47
7.1.3 POLYMERASE CHAIN REACTION (PCR) 49
7.1.4 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) 50
7.1.5 DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS) 51
7.1.6 DNA MICROARRAY 52
7.1.7 OTHER TECHNOLOGIES 53
8 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE 55
8.1 INTRODUCTION 56
8.1.1 HEPATITIS 57
8.1.1.1 Hepatitis diagnostics market, by technology 58
8.1.2 HUMAN IMMUNODEFICIENCY VIRUS (HIV) 59
8.1.3 CHLAMYDIA TRACHOMATIS GENITAL INFECTION AND GONORRHEA (CT/NG) 60
8.1.4 HOSPITAL-ACQUIRED INFECTIONS (HAIS) 61
8.1.5 HUMAN PAPILLOMAVIRUS (HPV) 62
8.1.6 TUBERCULOSIS (TB) 63
8.1.6.1 Tuberculosis diagnostics market, by technology 64
8.1.7 INFLUENZA 65
8.1.7.1 Influenza diagnostics market, by technology 66
8.1.8 OTHER INFECTIOUS DISEASES 66
9 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER 68
9.1 INTRODUCTION 69
9.2 HOSPITAL/CLINICAL LABORATORIES 70
9.3 REFERENCE LABORATORIES 71
9.4 PHYSICIAN OFFICES 72
9.5 ACADEMIC/RESEARCH INSTITUTES 73
9.6 OTHER END USERS 74
10 INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION 76
10.1 INTRODUCTION 77
10.2 NORTH AMERICA 78
10.2.1 US 82
10.2.2 CANADA 85
10.3 EUROPE 88
10.4 ASIA PACIFIC (APAC) 91
10.5 REST OF THE WORLD (ROW) 95
11 COMPETITIVE LANDSCAPE 98
11.1 MARKET OVERVIEW 98
11.2 MARKET RANKING ANALYSIS, 2017 99
11.3 COMPETITIVE SITUATION AND TRENDS 100
11.3.1 PRODUCT LAUNCHES AND APPROVALS 100
11.3.2 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS 101
11.3.3 ACQUISITIONS 102
11.3.4 EXPANSIONS 103
12 COMPANY PROFILES 104
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 ABBOTT LABORATORIES 104
12.2 BECTON, DICKINSON AND COMPANY 108
12.3 BIOMÉRIEUX SA 112
12.4 BIO-RAD LABORATORIES 118
12.5 DANAHER CORPORATION 123
12.6 DIASORIN 130
12.7 LUMINEX 136
12.8 MERIDIAN BIOSCIENCE 139
12.9 QUIDEL 143
12.10 ROCHE DIAGNOSTICS 148
12.11 SIEMENS AG 152
12.12 THERMO FISHER SCIENTIFIC 156

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13 APPENDIX 161
13.1 DISCUSSION GUIDE 161
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 164
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 166
13.4 AVAILABLE CUSTOMIZATIONS 168
13.5 RELATED REPORTS 169
13.6 AUTHOR DETAILS 170

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+